(Q38248158)

1 September 2017

1 reference

title

Monitoring biomarkers of cellular injury and death in acute brain injury (English)

1 reference

1 September 2017

0 references

Sherry H-Y Chou

1

1 reference

1 September 2017

Claudia S Robertson

series ordinal

2

1 reference

1 September 2017

Participants in the International Multi-disciplinary Consensus Conference on the Multimodality Monitoring

series ordinal

3

1 reference

1 September 2017

1 December 2014

1 reference

1 September 2017

1 reference

1 September 2017

21 Suppl 2

1 reference

1 September 2017

S187-214

1 reference

https://scigraph.springernature.com/pub.10.1007/s12028-014-0039-z

1 September 2017

0 references

cites work

Outcome after cardiac arrest: predictive values and limitations of the neuroproteins neuron-specific enolase and protein S-100 and the Glasgow Coma Scale.

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Serum neuron-specific enolase predicts outcome in post-anoxic coma: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Serum S-100 and neuron-specific enolase for prediction of regaining consciousness after global cerebral ischemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Time course of serum neuron-specific enolase. A predictor of neurological outcome in patients resuscitated from cardiac arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Serum levels of the brain-derived proteins S-100 and NSE predict long-term outcome after cardiac arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Serum neuron-specific enolase levels from the same patients differ between laboratories: assessment of a prospective post-cardiac arrest cohort.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

S-100 protein as early predictor of regaining consciousness after out of hospital cardiac arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

B-type natriuretic peptide as a marker of resuscitation in patients with cardiac arrest outside the hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Can brain natriuretic peptide predict outcome after cardiac arrest? An observational study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

CSF and serum brain-specific creatine kinase isoenzyme (CK-BB), neuron-specific enolase (NSE) and neural cell adhesion molecule (NCAM) as prognostic markers for hypoxic brain injury after cardiac arrest in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Cerebrospinal fluid creatine kinase BB isoenzyme activity and neurologic prognosis after cardiac arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

CSF levels of neurofilament is a valuable predictor of long-term outcome after cardiac arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Neurological prognostication after cardiac arrest--recommendations from the Swedish Resuscitation Council.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Serum S-100B is superior to neuron-specific enolase as an early prognostic biomarker for neurological outcome following cardiopulmonary resuscitation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Serum neuron-specific enolase as predictor of outcome in comatose cardiac-arrest survivors: a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Neuron specific enolase and S-100B as predictors of outcome after cardiac arrest and induced hypothermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Modeling serum biomarkers S100 beta and neuron-specific enolase as predictors of outcome after out-of-hospital cardiac arrest: an aid to clinical decision making

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Serum neuron-specific enolase and S-100B protein in cardiac arrest patients treated with hypothermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Modeling serum level of s100β and bispectral index to predict outcome after cardiac arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Neuron-specific enolase correlates with other prognostic markers after cardiac arrest.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

S-100B is superior to NSE, BDNF and GFAP in predicting outcome of resuscitation from cardiac arrest with hypothermia treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

The prognostic value of serum S-100B protein in spontaneous subarachnoid haemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

S-100B and NSE: markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Subarachnoid hemorrhage and inflammation: bench to bedside and back

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Cerebral vasospasm after subarachnoid hemorrhage: putative role of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Leukocytosis as an independent risk factor for cerebral vasospasm following aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Elevated peripheral neutrophils and matrix metalloproteinase 9 as biomarkers of functional outcome following subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Prediction of mortality by hematological parameters on admission in patients with subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

The burden of the systemic inflammatory response predicts vasospasm and outcome after subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Acute systemic inflammatory response syndrome in subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Early circulating levels of endothelial cell activation markers in aneurysmal subarachnoid haemorrhage: associations with cerebral ischaemic events and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Reduced ADAMTS13 activity in delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Early elevation of serum tumor necrosis factor-α is associated with poor outcome in subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Brain interstitial fluid TNF-alpha after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Inflammatory cytokines in subarachnoid haemorrhage: association with abnormal blood flow velocities in basal cerebral arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Cerebrospinal fluid interleukin-1 receptor antagonist and tumor necrosis factor-alpha following subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Ventricular cerebrospinal fluid and serum concentrations of sTNFR-I, IL-1ra, and IL-6 after aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

High ICP as trigger of proinflammatory IL-6 cytokine activation in aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

S-nitrosylation of matrix metalloproteinases: signaling pathway to neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Serum von Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Characterization of plasma gelsolin as a substrate for matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Role of plasma gelsolin and the vitamin D-binding protein in clearing actin from the circulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Angiopathic consequences of saturating the plasma scavenger system for actin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

The protective effects of plasma gelsolin on stroke outcome in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Plasma-type gelsolin is decreased in human blood and cerebrospinal fluid after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Plasma gelsolin levels and outcomes after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Temporal relationship between endothelin-1 concentrations and cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Raised plasma endothelin in aneurysmal subarachnoid haemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Endothelin and aneurysmal subarachnoid haemorrhage: a study of subarachnoid cisternal cerebrospinal fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Clazosentan, an endothelin receptor antagonist, in patients with aneurysmal subarachnoid haemorrhage undergoing surgical clipping: a randomised, double-blind, placebo-controlled phase 3 trial (CONSCIOUS-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Apolipoprotein E genotype and outcome after aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

APOE influences vasospasm and cognition of noncomatose patients with subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Meta-analysis of APOE genotype and subarachnoid hemorrhage: clinical outcome and delayed ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Decreased cerebrospinal fluid apolipoprotein E after subarachnoid hemorrhage: correlation with injury severity and clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Cardiac troponin-I: a predictor of prognosis in subarachnoid hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Cardiovascular predictors of in-patient mortality after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Brain natriuretic peptide concentrations after aneurysmal subarachnoid hemorrhage: relationship with hypovolemia and hyponatremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Correlation of serum brain natriuretic peptide with hyponatremia and delayed ischemic neurological deficits after subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Elevated BNP is associated with vasospasm-independent cerebral infarction following aneurysmal subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Cerebrospinal fluid catecholamine levels as predictors of outcome in subarachnoid hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

S-100 protein and neuron-specific enolase concentrations in blood as indicators of infarction volume and prognosis in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Evaluation of serum S100B as a surrogate marker for long-term outcome and infarct volume in acute middle cerebral artery infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

S100B as a surrogate marker for successful clot lysis in hyperacute middle cerebral artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Serum S100B predicts a malignant course of infarction in patients with acute middle cerebral artery occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Human C-reactive protein increases cerebral infarct size after middle cerebral artery occlusion in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

High-sensitivity C-reactive protein is a strong risk factor for death after acute ischemic stroke among Chinese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Elevated C-reactive protein and long-term mortality after ischaemic stroke: relationship with markers of endothelial cell and platelet activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

C-reactive protein in the very early phase of acute ischemic stroke: association with poor outcome and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Admission C-reactive protein after acute ischemic stroke is associated with stroke severity and mortality: the 'Bergen stroke study'.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Prognostic relevance of early serial C-reactive protein measurements after first ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Admission leukocytosis in acute cerebral ischemia: influence on early outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Prognostic significance of plasma visfatin levels in patients with ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Plasminogen activators and matrix metalloproteases, mediators of extracellular proteolysis in inflammatory demyelination of the central nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Blood-brain barrier disruption in humans is independently associated with increased matrix metalloproteinase-9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Extracellular proteolysis in brain injury and inflammation: role for plasminogen activators and matrix metalloproteinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Increase in Plasma Matrix Metalloproteinase-9 in Acute Stroke Patients With Thrombolysis Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke: a multicenter confirmatory study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Matrix metalloproteinase expression is related to hemorrhagic transformation after cardioembolic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Unriddling the role of matrix metalloproteinases in human cerebral stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Matrix metalloproteinase 9 mRNA: an early prognostic marker for patients with acute stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

The prediction of malignant cerebral infarction by molecular brain barrier disruption markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Increased plasma endothelin-1 in acute ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Serum tight-junction proteins predict hemorrhagic transformation in ischemic stroke patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Serum uric acid and outcome after acute ischemic stroke: PREMIER study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Relationship between plasma (D)-dimer level and cerebral infarction volume in patients with nonvalvular atrial fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Change in plasma S100B level after acute spontaneous basal ganglia hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

S100B and brain natriuretic peptide predict functional neurological outcome after intracerebral haemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Temporal profile and clinical significance of serum neuron-specific enolase and S100 in ischemic and hemorrhagic stroke.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Serum-myelin-basic-protein assay in diagnosis and prognosis of patients with head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Biochemical serum markers of traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Predictive value of phosphorylated axonal neurofilament subunit H for clinical outcome in patients with acute intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Molecular signatures of brain injury after intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Peripheral leukocyte counts and outcomes after intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

C-reactive-protein levels associated with infection predict short- and long-term outcome after supratentorial intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

The association between serum adhesion molecules and outcome in acute spontaneous intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

VAP-1/SSAO plasma activity and brain expression in human hemorrhagic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Plasma interleukin 11 levels correlate with outcome of spontaneous intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Admission plasma visfatin level strongly correlates with hematoma growth and early neurologic deterioration in patients with acute spontaneous basal ganglia hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

High concentrations of visfatin in the peripheral blood of patients with acute basal ganglia hemorrhage are associated with poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Prognostic value of leptin: 6-month outcome in patients with intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Matrix metalloproteinase-9 concentration after spontaneous intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Temporal profile of matrix metalloproteinases and their inhibitors after spontaneous intracerebral hemorrhage: relationship to clinical and radiological outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Association of molecular markers with perihematomal edema and clinical outcome in intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Significant reduction of plasma gelsolin levels in patients with intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Serum D-dimer as a predictor of mortality in patients with acute spontaneous intracerebral hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Serum cholesterol LDL and 90-day mortality in patients with intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

High concentrations of procoagulant microparticles in the cerebrospinal fluid and peripheral blood of patients with acute basal ganglia hemorrhage are associated with poor outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Role of S100B protein in urine and serum as an early predictor of mortality after severe traumatic brain injury in adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Serum S 100 B: a marker of brain damage in traumatic brain injury with and without multiple trauma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Correlation of computed tomography findings and serum brain damage markers following severe head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Predicting outcome after severe traumatic brain injury using the serum S100B biomarker: results using a single (24h) time-point

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

S100B is an important outcome predictor in traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Outcome prediction in traumatic brain injury: comparison of neurological status, CT findings, and blood levels of S100B and GFAP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

GFAP versus S100B in serum after traumatic brain injury: relationship to brain damage and outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Predictive value of S-100β protein for prognosis in patients with moderate and severe traumatic brain injury: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

GFAP and S100B in the acute phase of mild traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

S-100B and neuron specific enolase are poor outcome predictors in severe traumatic brain injury treated by an intracranial pressure targeted therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

The value of serum biomarkers in prediction models of outcome after mild traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Neuron-specific enolase as an aid to outcome prediction in head injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Tau proteins in serum predict outcome after severe traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

GFAP and S100B are biomarkers of traumatic brain injury: an observational cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Increased serum-GFAP in patients with severe traumatic brain injury is related to outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

GFAP-BDP as an acute diagnostic marker in traumatic brain injury: results from the prospective transforming research and clinical knowledge in traumatic brain injury study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Neuronal and glial markers are differently associated with computed tomography findings and outcome in patients with severe traumatic brain injury: a case control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Biokinetic analysis of ubiquitin C-terminal hydrolase-L1 (UCH-L1) in severe traumatic brain injury patient biofluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Serum levels of ubiquitin C-terminal hydrolase distinguish mild traumatic brain injury from trauma controls and are elevated in mild and moderate traumatic brain injury patients with intracranial lesions and neurosurgical intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

alphaII-Spectrin breakdown product cerebrospinal fluid exposure metrics suggest differences in cellular injury mechanisms after severe traumatic brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

The window of risk in repeated head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Brain injury biomarkers may improve the predictive power of the IMPACT outcome calculator

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Neuron-specific enolase and S100BB as outcome predictors in severe diffuse axonal injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

The blood leukocyte count and its prognostic significance in severe head injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Use of serum biomarkers to predict secondary insults following severe traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Interleukin-10 is an independent biomarker of severe traumatic brain injury prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Prognostic value of interleukin-1 beta levels after acute brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Association between cerebrospinal fluid interleukin-6 concentrations and outcome after severe human traumatic brain injury.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Research and technology in neurocritical care

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12028-014-0039-Z

Early EEG correlates of neuronal injury after brain anoxia

21 January 2018

1 reference

12 December 2020

C-reactive protein level measurement improves mortality prediction when added to the spontaneous intracerebral hemorrhage score

1 reference

12 December 2020

Neurological outcome after out-of-hospital cardiac arrest. Prediction by cerebrospinal fluid enzyme analysis

1 reference

12 December 2020

Relationship between leukocytosis and ischemic complications following aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Serum levels of S100B, S100A1B and S100BB are all related to outcome after severe traumatic brain injury

1 reference

12 December 2020

Decreased plasma gelsolin is associated with 1-year outcome in patients with traumatic brain injury.

1 reference

12 December 2020

The value of serial plasma nuclear and mitochondrial DNA levels in acute spontaneous intra-cerebral haemorrhage

1 reference

12 December 2020

Clinical utility of serum levels of ubiquitin C-terminal hydrolase as a biomarker for severe traumatic brain injury.

1 reference

12 December 2020

Protein S-100B and neuron specific enolase as early neurobiochemical markers of the severity of traumatic brain injury

1 reference

12 December 2020

Relation of serum TNF-α and TNF-α genotype with delayed cerebral ischemia and outcome in subarachnoid hemorrhage

1 reference

12 December 2020

Endothelin in plasma and cerebrospinal fluid of patients with subarachnoid haemorrhage

1 reference

12 December 2020

Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma

1 reference

12 December 2020

Apolipoprotein e genotype and outcome in aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Soluble endoglin and transforming growth factor-β₁ and the development of vasospasm after spontaneous subarachnoid hemorrhage: a pilot study

1 reference

12 December 2020

Diagnostic significance of serum neuron-specific enolase and myelin basic protein assay in patients with acute head injury

1 reference

12 December 2020

The blood leukocyte count and its prognostic significance in subarachnoid hemorrhage

1 reference

12 December 2020

Association of apolipoprotein E polymorphism with outcome after aneurysmal subarachnoid hemorrhage: a preliminary study

1 reference

12 December 2020

Acute biomarkers of traumatic brain injury: relationship between plasma levels of ubiquitin C-terminal hydrolase-L1 and glial fibrillary acidic protein

1 reference

12 December 2020

Prediction of poor outcome within the first 3 days of postanoxic coma

1 reference

12 December 2020

Correlation between blood parameters and symptomatic vasospasm in subarachnoid hemorrhage patients

1 reference

12 December 2020

Plasma S100B level after acute spontaneous intracerebral hemorrhage

1 reference

12 December 2020

Vascular matrix metalloproteinase-2 cleaves big endothelin-1 yielding a novel vasoconstrictor

1 reference

12 December 2020

Matrix metalloproteinases regulate neutrophil-endothelial cell adhesion through generation of endothelin-1[1-32]

1 reference

12 December 2020

Daily trends in white blood cell count and temperature after subarachnoid hemorrhage from aneurysm

1 reference

12 December 2020

Predictive value of leucocytosis in head trauma.

1 reference

12 December 2020

High serum levels of endothelin-1 predict severe cerebral edema in patients with acute ischemic stroke treated with t-PA

1 reference

12 December 2020

Cardiac troponin elevation, cardiovascular morbidity, and outcome after subarachnoid hemorrhage

1 reference

12 December 2020

Copeptin is associated with one-year mortality and functional outcome in patients with acute spontaneous basal ganglia hemorrhage

1 reference

12 December 2020

Oxidative markers in spontaneous intracerebral hemorrhage: leukocyte 8-hydroxy-2'-deoxyguanosine as an independent predictor of the 30-day outcome

1 reference

12 December 2020

S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage

1 reference

12 December 2020

The prognostic value of serum tau in patients with intracerebral hemorrhage

1 reference

12 December 2020

Serum neuron-specific enolase, S100B, and myelin basic protein concentrations after inflicted and noninflicted traumatic brain injury in children

1 reference

12 December 2020

Release of glial tissue-specific proteins after acute stroke: A comparative analysis of serum concentrations of protein S-100B and glial fibrillary acidic protein

1 reference

12 December 2020

Poststroke C-reactive protein is a powerful prognostic tool among candidates for thrombolysis

1 reference

12 December 2020

Somatosensory potentials, CSF creatine kinase BB activity, and awakening after cardiac arrest

1 reference

12 December 2020

Prognostic value of venous blood ammonia in patients with out-of-hospital cardiac arrest

1 reference

12 December 2020

Outcome prediction with serum intercellular adhesion molecule-1 levels after aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Different prognostic value of white blood cell subtypes in patients with acute cerebral infarction

1 reference

12 December 2020

Change in plasma gelsolin level after traumatic brain injury.

1 reference

12 December 2020

Mechanisms of early brain injury after SAH: matrix metalloproteinase 9

1 reference

12 December 2020

Elevated troponin levels are associated with higher mortality following intracerebral hemorrhage

1 reference

12 December 2020

Interleukin-6 plasmatic levels in patients with head trauma and intracerebral hemorrhage.

1 reference

12 December 2020

Prediction of the neurological outcome with intrathecal high mobility group box 1 and S100B in cardiac arrest victims: a pilot study

1 reference

12 December 2020

Blood ammonia and lactate levels on hospital arrival as a predictive biomarker in patients with out-of-hospital cardiac arrest

1 reference

12 December 2020

Cerebral vasospasm and vasoconstriction caused by endothelin

1 reference

12 December 2020

Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke

1 reference

12 December 2020

Prognostication after cardiac arrest and hypothermia: a prospective study.

1 reference

12 December 2020

Circulating MicroRNAs as potential risk biomarkers for hematoma enlargement after intracerebral hemorrhage

1 reference

12 December 2020

Serum low-density lipoprotein cholesterol level predicts hematoma growth and clinical outcome after acute intracerebral hemorrhage

1 reference

12 December 2020

Prognostic value of admission C-reactive protein in stroke patients undergoing iv thrombolysis

1 reference

12 December 2020

Cerebrospinal fluid creatine kinase-BB isoenzyme activity and outcome after subarachnoid hemorrhage

1 reference

12 December 2020

The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage

1 reference

12 December 2020

Plasma endothelin-1 levels neither increase nor correlate with neurological scores, stroke risk factors, or outcome in patients with ischemic stroke

1 reference

12 December 2020

10.1007/S12028-014-0039-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

1 September 2017

0 references

0 references

1 reference